Terms: = Leukemia AND CEACAM5, CEA
96 results:
1. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis.
Yu S; Zhao H; Meng H; Shi S; Cao S; Bian T; Ruan C
Genet Res (Camb); 2023; 2023():8586507. PubMed ID: 37113556
[TBL] [Abstract] [Full Text] [Related]
2. [Prognostic Value of the Expression of Myeloid leukemia Factor 1-Interacting Protein in Gastric Cancer and Its Regulatory Role in Tumor Progression].
Yang Z; Zhang H; Xu MY; Zhang XF; Wang YY; Ge ST; Geng ZJ; Song X; Li J; Hu JG; Zuo LG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):114-121. PubMed ID: 36647653
[TBL] [Abstract] [Full Text] [Related]
3. The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia.
Conti RM; Padula WV; Becker RV; Salamone S
J Manag Care Spec Pharm; 2021 Aug; 27(8):1077-1085. PubMed ID: 34337991
[No Abstract] [Full Text] [Related]
4. Oncolytic viruses as a promising therapeutic strategy against the detrimental health impacts of air pollution: The case of glioblastoma multiforme.
Kazemi Shariat Panahi H; Dehhaghi M; Lam SS; Peng W; Aghbashlo M; Tabatabaei M; Guillemin GJ
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1122-1142. PubMed ID: 34004331
[TBL] [Abstract] [Full Text] [Related]
5. Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method.
Inaba S; Shimozono N; Yabuki H; Enomoto M; Morishita M; Hirotsu T; di Luccio E
Cancer Treat Res Commun; 2021; 27():100370. PubMed ID: 33901923
[TBL] [Abstract] [Full Text] [Related]
6. Identification of hub genes associated with adult acute myeloid leukemia progression through weighted gene co-expression network analysis.
Zhu R; Lin W; Tang L; Hu Y
Aging (Albany NY); 2021 Feb; 13(4):5686-5697. PubMed ID: 33592582
[TBL] [Abstract] [Full Text] [Related]
7. leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer.
Jiang W; Bai W; Li J; Liu J; Zhao K; Ren L
Int J Cancer; 2021 Feb; 148(4):1006-1013. PubMed ID: 32914874
[TBL] [Abstract] [Full Text] [Related]
8. Influence of Internal and External Factors on the Production of Cytokines by Peripheral Blood Cells in Breast Cancer.
Autenshlyus AI; Davletova KI; Mikhaylova ES; Proskura AV; Varaksin NA; Bogachuk AP; Sidorov SV; Lyakhovich VV; Lipkin VM
Dokl Biochem Biophys; 2020 Jul; 493(1):178-180. PubMed ID: 32894459
[TBL] [Abstract] [Full Text] [Related]
9. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
[TBL] [Abstract] [Full Text] [Related]
10. Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment.
Zhao Z; Xiao X; Saw PE; Wu W; Huang H; Chen J; Nie Y
Sci China Life Sci; 2020 Feb; 63(2):180-205. PubMed ID: 31883066
[TBL] [Abstract] [Full Text] [Related]
11. Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30
Hombach AA; Rappl G; Abken H
Mol Ther; 2019 Oct; 27(10):1825-1835. PubMed ID: 31331813
[TBL] [Abstract] [Full Text] [Related]
12. A distinguished cancer-screening package containing a DNA sensor and an aptasensor for early and certain detection of acute lymphoblastic leukemia.
Mazloum-Ardakani M; Barazesh B; Moshtaghiun SM
Clin Chim Acta; 2019 Oct; 497():41-47. PubMed ID: 31295447
[TBL] [Abstract] [Full Text] [Related]
13. Systematic review protocol: an assessment of the post-approval challenges of autologous CAR-T therapy delivery.
Lam C; Meinert E; Halioua-Haubold CL; Carter A; Yang A; Brindley D; Cui Z
BMJ Open; 2019 Jul; 9(7):e026172. PubMed ID: 31278092
[TBL] [Abstract] [Full Text] [Related]
14. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
[No Abstract] [Full Text] [Related]
15. Molecular Imaging of Radiolabeled Bispecific T-Cell Engager
Waaijer SJH; Warnders FJ; Stienen S; Friedrich M; Sternjak A; Cheung HK; van Scheltinga AGTT; Schröder CP; de Vries EGE; Lub-de Hooge MN
Clin Cancer Res; 2018 Oct; 24(20):4988-4996. PubMed ID: 29980531
[No Abstract] [Full Text] [Related]
16. Impact of microRNA-375 and its target gene SMAD-7 polymorphism on susceptibility of colorectal cancer.
Shaker OG; Mohammed SR; Mohammed AM; Mahmoud Z
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374902
[TBL] [Abstract] [Full Text] [Related]
17. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract] [Full Text] [Related]
18. External radiation dose and cancer mortality among French nuclear workers: considering potential confounding by internal radiation exposure.
Fournier L; Laurent O; Samson E; Caër-Lorho S; Laroche P; Le Guen B; Laurier D; Leuraud K
Int Arch Occup Environ Health; 2016 Nov; 89(8):1183-1191. PubMed ID: 27383840
[TBL] [Abstract] [Full Text] [Related]
19. Harnessing T cells to fight cancer with BiTE® antibody constructs--past developments and future directions.
Klinger M; Benjamin J; Kischel R; Stienen S; Zugmaier G
Immunol Rev; 2016 Mar; 270(1):193-208. PubMed ID: 26864113
[TBL] [Abstract] [Full Text] [Related]
20. CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.
Uehara K; Ikehara F; Tanabe Y; Nakazato I; Oshiro M; Inamine M; Kinjo T
Diagn Pathol; 2016 Feb; 11():16. PubMed ID: 26830028
[TBL] [Abstract] [Full Text] [Related]
[Next]
